Sofinnova Investments, Inc. Tcr2 Therapeutics Inc. Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$8.44 - $18.35 $2.5 Million - $5.44 Million	-296,282 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$16.41 - $24.71 $662,964 - $998,284	-40,400 Reduced 12.0%	296,282 $4.86 Million
Q1 2021 May 14, 2021	BUY	$20.38 - $34.07 $60,630 - $101,358	2,975 Added 0.89%	336,682 $7.43 Million
Q4 2020 Feb 16, 2021	BUY	$19.0 - $32.63 $3.05 Million - $5.24 Million	160,679 Added 92.86%	333,707 $10.3 Million
Q3 2020 Nov 13, 2020	BUY	$13.1 - $20.69 $2.27 Million - $3.58 Million	173,028 New	173,028 $3.52 Million

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.